CTIS2023-508769-33-00进行中（未招募）1 期
Protocol with Progestin-primed Ovarian Stimulation (PPOS) in conventional treatment from the start of stimulation vs protocol with GnRH antagonists as a pituitary suppressor in patients who are going to undergo DUOSTIM with embryo accumulation for PGT-A of the embryos.
Ginefiv S.L.0 个研究点目标入组 144 人开始时间: 2023年11月29日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 144
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •1.Age less than 43 years . 2.Regular menstrual cycles between 21 and 35 days. 3.Indication for IVF with PGT-A 4. Both ovaries present. 5. Ability to participate and complete the study. 6. Give and sign consent to participate in the study.
排除标准
- •1.Endometriosis grade III/IV 2.Concurrent participation in another study
研究者
相似试验
已完成
不适用
Ovarian stimulation with follicle stimulating hormone (r-FSH) for women with high early follicular FSH and intra-uterine insemination (IUI) indicatioISRCTN14825568VU University Medical Centre (VUMC) (Netherlands)80
尚未招募
4 期
Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.Stimulation in the OvaryEmbryoOocyteOocyte RetrievalFertilization in VitroBlastocystPGT-ANCT06637189Ginefiv144
招募中
4 期
The efficacy of progestin primed ovarian stimulation (PPOS) using Dienogest v.s. antagonist method during controlled ovarian stimulation(COS) for patients with endometriosisinfertilityJPRN-UMIN000044076Kamiya Ladies Clinic80
进行中（未招募）
1 期
Initiation of ovarian stimulation in the late follicular phaseSubfertility Oocyte donationMedDRA version: 20.0 Level: LLT Classification code 10042392 Term: Subfertility (female) System Organ Class: 100000004872MedDRA version: 20.0 Level: PT Classification code 10053370 Term: Oocyte donation System Organ Class: 10042613 - Surgical and medical proceduresEUCTR2017-005005-12-BEZ Brussel62
已完成
不适用
Controlled ovarian stimulation and intrauterine insemination or in vitro-fertilisation for the first line treatment of unexplained infertilityBest first line treatment options for unexplained infertilityPregnancy and ChildbirthInfertilityISRCTN43430382Homerton University Hospital (UK)320